$INBP News
Last published 10h ago
- 10h agoINBPINTEGRATED BIOPHARMA INC - EXHIBIT 99.1 PRESS RELEASE NOVEMBER 13 2026Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 10h agoINBPIntegrated BioPharma Reports Results for its Quarter Ended September 30, 2026ACCESS NewswireIntegrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2026. Revenue for the quarters ended September 30, 2026 was $9.9 million compared to $12.7 million for the quarter ended September 30, 2025, a decrease of $2.8 million or approximately 22.0%. The Company had an operating loss of $1.0 million in the quarter ended Septe ...
- 3y agoINBPIntegrated BioPharma Reports Results for its Quarter Ended December 31, 2022ACCESS NewswireHILLSIDE, NJ / ACCESSWIRE / February 10, 2023 / Integrated BioPharma, Inc. ) reports its financial results for the quarter ended December 31, 2022.Revenue for the
- 4y agoINBPIntegrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022ACCESS NewswireHILLSIDE, NJ / ACCESSWIRE / September 13, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2022. Revenue for the quarter ended June 30, 2022 was $13.3 m
- 4y agoINBPIntegrated BioPharma Announces Change in DirectorsACCESS NewswireHILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr. Carl DeSantis has resigned as a Class I Director from the Company's Board of Directors and Mr. Damon DeSantis, has been elec
- 4y agoINBPIntegrated BioPharma Reports Results for its Quarter Ended March 31, 2022ACCESS NewswireHILLSIDE, NJ / ACCESSWIRE / May 12, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the fiscal quarter ended March 31, 2022. Revenue for the three-month period ended March 31, 2022 was $15.6 mil
- 4y agoINBPIntegrated BioPharma Reports Results for its Quarter Ended December 31, 2021ACCESS NewswireHILLSIDE, NJ / ACCESSWIRE / February 10, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2021. Revenue for the quarter ended December 31, 2021 was $14.6 million co
- 5y agoINBPIntegrated BioPharma Reports Results for its Quarter Ended September 30, 2021ACCESS NewswireHILLSIDE, NJ / ACCESSWIRE / November 10, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2021. Revenue for the quarter ended September 30, 2021 was $12.8 million
- 5y agoINBPIntegrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021ACCESS NewswireHILLSIDE, NJ / ACCESSWIRE / September 2, 2021 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2021. Revenue for the quarter ended June 30, 2021 was $17.1 mi
- 5y agoINBPIntegrated BioPharma Reports Results for its Quarter Ended March 31, 2021ACCESS NewswireHILLSIDE, NJ / ACCESSWIRE / May 13, 2021 / Integrated BioPharma, Inc. ((OTCQX: INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2021. Revenue for the quarter ended March 31, 2021 was $17.1 million compared